Positive PsychoTherapy in Acquired Brain Injury (ABI) Rehabilitation
Launched by NHS GREATER GLASGOW AND CLYDE · Jun 3, 2013
Trial Information
Current as of September 10, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 years or over;
- • Diagnosis of stroke or acquired brain injury (confirmed clinically and/or radiologically);
- • Between 3 and 12 months post-injury at time of recruitment;
- • Presence of emotional distress (score in moderate or above range on at least one sub-scale of the Depression Anxiety Stress Scales; DASS-21);
- • Medically stable;
- • Able to consent to research.
- Exclusion Criteria:
- • Significant communication impairments that would preclude participation;
- • Diagnosis of mild traumatic brain injury (due to the known additional complexities contributing to outcome in this population);
- • Comorbid developmental learning disability or degenerative neurological condition.
- • Pre-injury history of mood disorder will not lead to exclusion.
About Nhs Greater Glasgow And Clyde
NHS Greater Glasgow and Clyde (NHS GG&C) is one of the largest health organizations in the UK, dedicated to delivering high-quality healthcare services to a diverse population. As a clinical trial sponsor, NHS GG&C plays a pivotal role in advancing medical research and improving patient outcomes through innovative clinical studies. The organization is committed to upholding rigorous ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost care for participant safety and scientific integrity. With a focus on collaboration, NHS GG&C partners with academic institutions, healthcare professionals, and industry stakeholders to foster an environment conducive to groundbreaking research and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glasgow, United Kingdom
Patients applied
Trial Officials
Jonathan Evans, PhD
Principal Investigator
University of Glasgow
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials